keratanase II

an endo-beta-N-acetylglucosaminidase; cleaves the beta(1-3)-glycosidic bond of a fucosylated 6-O-sulfated N-acetylglucosamine

Networked: 2 relevant articles (1 outcomes, 0 trials/studies)

1.	Neoplasms (Cancer) 09/01/1996 - "Blood group ABH antigens, which are simultaneously expressed together with keratan sulphate epitope in cancer cells, were eliminated by digestion with endo-beta-galactosidase and N-glycosidase F, but were resistant to keratanase and keratanase II treatment. "
2.	Spinal Cord Injuries (Spinal Cord Injury) 04/23/2015 - "Keratanase II or chondroitinase ABC was locally administered at the lesion after spinal cord injury at C3/4. Task-specific rehabilitation training, i.e., a single pellet reaching task using a Whishaw apparatus, was done for 3 weeks before injury, and then again at 1-6 weeks after injury. "
3.	Papillary Carcinoma 09/01/1996 - "The reactivity of 5-D-4 with papillary carcinomas was markedly reduced or abolished by prior digestion with endo-beta-galactosidase, keratanase II, or N-glycosidase F. "

1.	Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase
2.	Antigens
3.	Epitopes
4.	ABO Blood-Group System
5.	keratan-sulfate endo-1,4-beta-galactosidase
6.	Chondroitin ABC Lyase